Endovenous thermal ablation (EVTA), including radiofrequency ablation (RFA) and endovenous laser ablation (EVLA), is considered the main method for the treatment of symptomatic truncal vein reflux. However, there are controversial data concerning their efficacy and safety in ablating large saphenous veins because of high risk of heat-induced thrombosis (EHIT), incomplete ablation and recanalization.1-5 The use of vacuum evacuation of the remaining intraluminal blood during endovenous laser ablation allows to decrease the risk of intraoperative (carbonization and destruction of the fiber lens) and postoperative complications (EHIT, hyperpigmentation, "string" feeling) and leads to reduction of recovery because of short period of vein resorption. The aim of the study is to evaluate the safety and effectiveness of endovenous thermal ablation with or without vacuum evacuation for the treatment of incompetent large saphenous veins (\>15 mm).
Preoperatively all patients should be examined in a standing position clinically and with duplex ultrasound (DUS) marking of the diameters of the target great saphenous veins (GSV) or small saphenous veins (SSV) at the following levels: * great saphenous vein: saphenofemoral junction (SFJ), vein ectasia below the SFJ by 3 cm, upper third of the thigh, middle third of the thigh, lower third of the thigh, upper third of the leg, middle third of the leg, lower third of the leg; * small saphenous vein: saphenopopliteal junction (SPJ), ectasia below the SPJ by 3 cm, upper third of the leg, middle third of the leg, lower third of the leg. It is recommended to calculate the required linear energy density (LEED) per centimeter of vein length using the following formula depending on the level of measurement of the target vein diameter: LEED=d\*k, where LEED is the linear energy density (J/cm), "d" is the vein diameter (mm), "k" is the coefficient based on the measurement level: upper half of the thigh - 10, lower half of the thigh - 8, upper half of the leg - 6, lower half of the leg - 4. Under local anesthesia, the target vein is punctured and the introducer is then installed. For the first group of patients (ELVeS Radial 2ring fiber), there is no need for preliminary preparation of the fiber. For the second group (ELVeS Radial 2ring Pro fiber), it is recommended to fill the ELVes Radial 2ring Pro catheter with a pre-prepared heparin solution (200 ml 0.9% Na Cl + 1 ml (5000) heparin) before use. Passing the fiber and installing it in the orifice of the target vein. Performing tumescent anesthesia (1000 ml 0.9% NaCl, 10 ml 2% lidocaine, 0.25 ml 0.1% adrenaline, 56 ml 4% sodium bicarbonate at room temperature) with recording the volume of the solution used. Performing EVLA with recording the parameters at different levels (power, extraction rate). When performing laser obliteration in patients of the second group, the ELVeS Radial 2ring Pro fiber catheter is connected to a vacuum suction using a high-pressure line to evacuate residual blood from the lumen of the vein during EVLA. Compression underwear of class 2 according to RAL or class 3 according to ASQUAL (23-32 mm Hg).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
184
Great or small saphenous vein occlusion with endovenous laser ablation using ELVeS Radial 2ring fiber
Great or small saphenous vein occlusion with endovenous laser ablation using ELVeS Radial 2ring Pro fiber
Clinic in Uruchye
Minsk, Belarus
RECRUITINGMerci clinic
Minsk, Belarus
RECRUITINGSANTE clinic
Minsk, Belarus
RECRUITINGCenter Of Phlebology
Bishkek, Chuy Region, Kyrgyzstan
RECRUITINGLaser Surgery Center
Moscow, Russia
RECRUITINGInnovative vascular centre
Saint Petersburg, Russia
RECRUITINGDerzhavin Tambov State University
Tambov, Russia
RECRUITINGClinic of Modern Phlebology "VarikozOFF"
Tashkent, Uzbekistan
RECRUITINGClinic of Modern Phlebology "VarikozOFF"
Tashkent, Uzbekistan
RECRUITINGOcclusion of the treated GSV/SSV
Obliteration of varicose vein along the treated segment of the GSV/SSV measured using ultrasound (US) examination
Time frame: One day, 2 weeks, one month, 3 months and 6 months post treatment
Pain score and use of painkillers
A questionnaire including the Numeric Rating Scale (NRS) of pain is filled in by the patient. It is a numeric scale from 0 (no pain) to 10 (worst imaginable pain).
Time frame: One day, 2 weeks, one month, 3 months and 6 months post treatment
Clinical status
CEAP classification. The CEAP classification is a common descriptive platform for the reporting of diagnostic information in chronic venous disease, as well as a tool for regular patient documentation and management. The clinical component indicates disease severity, ranging from none (0 points) to active ulcers (6 points). The etiologic component denotes the venous disease as congenital, primary, or secondary in nature. The anatomic classification pinpoints the veins involved as superficial, deep, or perforating. The pathophysiologic classification identifies the presence of reflux in the superficial,communicating, or deep systems, as well as the existence of outflow obstruction.
Time frame: 2 weeks, one month, 3 months and 6 months post treatment
Severity of chronic venous diseases
Venous Clinical Severity Score (VCSS). The VCSS includes 9 hallmarks of venous disease, each scored on a severity scale from 0 to 3.
Time frame: 2 weeks, one month, 3 months and 6 months post treatment
Health related quality of life
A questionnaire Chronic Venous Insufficiency Questionnaire (CIVIQ 20) is filled in by the patient. The CIVIQ comprises 20 questions in four quality-of-life domains: physical, psychological, social, and pain.The result ranges from 0 to 100.
Time frame: one month, 3 months and 6 months post treatment
Histological picture of the treated vein
A time period of connective tissue transformation of the vein wall and its lysis assessed by histochemical analysis (Picro-Mallory, Martius-Scarlet-Blue, Fuchsin-Miller)
Time frame: 2 weeks, one month, 3 months post treatment
Number of patients with adverse events
Major complications: superficial and deep venous thrombosis including EHIT, nerve injury, skin burns, and subcutaneous infections. Minor complications: ecchymosis and hyperpigmentation
Time frame: One day, 2 weeks, one month, 3 months and 6 months post treatment
Severity of hyperpigmentation
Skin tone estimated using the Pantone SkinTone Guide and compared with an unchanged area of skin
Time frame: 2 weeks, one month, 3 months and 6 months post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.